AARTIDRUGS

Aarti Drugs Ltd., incorporated in 1984, operates in the pharmaceuticals and specialty chemicals industries. The company manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical intermediates, specialty chemicals, and finished dosage formulations. It follows a vertically integrated business model and exports its APIs and specialty chemicals to over 100 countries across six continents. Aarti Drugs Ltd. includes Pinnacle Life Science Private Limited, its wholly-owned subsidiary focused on finished dosage formulations. The company holds leadership positions in therapeutic categories such as anti-protozoals and anti-inflammatory drugs. As part of the Aarti Group of Industries, valued at $1 billion, Aarti Drugs Ltd. has grown into a global leader for several high-volume molecules.